Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Beernink

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Vaccine|November 13, 2015
Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccineSerena Giuntini, Peter T Beernink, Dan M Granoff
Vaccine|September 17, 2013
Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic miceRaffaella Rossi, Dan M Granoff, Peter T Beernink
Clinical and Vaccine Immunology : CVI|June 7, 2013
Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Dan M Granoff, Sanjay Ram, Peter T Beernink
Plos One|August 19, 2015
A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbpMonica Konar, Peter T Beernink, Dan M Granoff
Infection and Immunity|May 23, 2012
Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor HRolando Pajon, Peter T Beernink, Dan M Granoff
Clinical and Vaccine Immunology : CVI|June 4, 2010
Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor h bindingPeter T Beernink, Jutamas Shaughnessy, Sanjay Ram, et al.
Biological Chemistry|December 13, 2003
Thermodynamic analysis of the dissociation of the aldolase tetramer substituted at one or both of the subunit interfacesDean R Tolan, Benjamin Schuler, Peter T Beernink, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2015
Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C VaccineRaffaella Rossi, Peter T Beernink, Serena Giuntini, et al.
Infection and Immunity|November 3, 2010
Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human bloodKathleen Y Dunphy, Peter T Beernink, Barbara Brogioni, et al.
Plos One|March 31, 2012
Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activitySerena Giuntini, Peter T Beernink, Donald C Reason, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Vaccine|November 13, 2015
Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccineSerena Giuntini, Peter T Beernink, Dan M Granoff
Vaccine|September 17, 2013
Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic miceRaffaella Rossi, Dan M Granoff, Peter T Beernink
Clinical and Vaccine Immunology : CVI|June 7, 2013
Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Dan M Granoff, Sanjay Ram, Peter T Beernink
Plos One|August 19, 2015
A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbpMonica Konar, Peter T Beernink, Dan M Granoff
Infection and Immunity|May 23, 2012
Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor HRolando Pajon, Peter T Beernink, Dan M Granoff
Clinical and Vaccine Immunology : CVI|June 4, 2010
Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor h bindingPeter T Beernink, Jutamas Shaughnessy, Sanjay Ram, et al.
Biological Chemistry|December 13, 2003
Thermodynamic analysis of the dissociation of the aldolase tetramer substituted at one or both of the subunit interfacesDean R Tolan, Benjamin Schuler, Peter T Beernink, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2015
Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C VaccineRaffaella Rossi, Peter T Beernink, Serena Giuntini, et al.
Infection and Immunity|November 3, 2010
Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human bloodKathleen Y Dunphy, Peter T Beernink, Barbara Brogioni, et al.
Plos One|March 31, 2012
Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activitySerena Giuntini, Peter T Beernink, Donald C Reason, et al.
Pageof 5